News
04-07-2009, 08:02 AM
Celsion Corporation has announced that promising Phase I clinical results evaluating ThermoDox for the treatment of recurrent chest wall (RCW) breast cancer were presented by Duke University investigators on Sunday, April 5 at the 2009 Annual Meeting of the Society for Thermal Medicine (STM) in Tucson, Arizona.
More... (http://www.news-medical.net/?id=47999)
More... (http://www.news-medical.net/?id=47999)